Tune Therapeutics
Durham
About Tune Therapeutics
Tune Therapeutics strives to develop paradigm-changing cell and gene therapies that leverage epigenetic programming for the treatment of devastating diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $215.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2025)
- Website: tunetx.com
- Phone: 98102-3788
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tune-therapeutics-53739 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.